GENE ONLINE|News &
Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?
Despite the availability of effective and inexpensive hormonal contraceptives, many women risk unintended pregnancies because of medical contraindications, or serious unpleasant or unbearable side-effects associated with the use of exogenous hormones.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
